PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL
- Authority
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Location
- Milano, Lombardia, Italy
- Deadline
- November 24, 2026
- Amount
- €460,000.00
- CPV
- Not available
- Official source
- Regione Lombardia — SINTEL (Socrata)
Tender — Authority: Fondazione IRCCS Istituto Nazionale dei Tumori — Location: Milano, Lombardia, Italy — Deadline: November 24, 2026 — Amount: €460,000.00.
Get alerts for similar opportunities
Hunt Report
The Report is written in the language you use Aralda in.
We are checking the tender documents.
The documents for this tender are not available for the Report. No payment has been requested.